The 2023 data on global ovary malignant neoplasms mortality highlights significant disparities across countries. The United States has the highest mortality, while Luxembourg and Iceland report the lowest deaths. Most countries demonstrate modest changes annually, with Brazil, Mexico, Peru, and Bulgaria witnessing noticeable mortality increases. Declines in Austria and Denmark are notable. Over five years, trends indicate an average increase in South Korea and Peru, reflecting varying healthcare infrastructure and awareness levels.
Looking ahead, key trends include potential mortality declines in developed countries through improved early detection and treatment. Countries with increasing trends should enhance healthcare services to mitigate ovarian cancer impacts.
Top countries in Ovary Malignant Neoplasms Mortality by Country
| # | 10 Countries | Units (Female Deaths) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 13,120 | 2023 | -0.79% | -0.94% | View data |
| 2 | 2 Germany | 5,160 | 2023 | -0.65% | -0.63% | View data |
| 3 | 3 Japan | 4,930 | 2023 | +0.55% | +0.59% | View data |
| 4 | 4 Brazil | 4,210 | 2023 | +1.84% | +1.1% | View data |
| 5 | 5 United Kingdom | 3,930 | 2023 | -0.41% | -0.9% | View data |
| 6 | 6 Mexico | 3,210 | 2023 | +3.42% | +4.5% | View data |
| 7 | 7 Poland | 2,840 | 2023 | +0.92% | +0.071% | View data |
| 8 | 8 Spain | 2,020 | 2023 | +0.25% | +0.76% | View data |
| 9 | 9 Canada | 1,840 | 2023 | +0.66% | +0.99% | View data |
| 10 | 10 South Korea | 1,450 | 2023 | +3.27% | +3.16% | View data |
